Steven L Krill

Title: Innovations of Steven L. Krill in Pharmaceutical Formulations

Introduction

Steven L. Krill is an accomplished inventor based in Park City, UT (US). He has made significant contributions to the field of pharmaceutical formulations, particularly in the area of drug delivery systems. His innovative approach focuses on improving the absorption and multistage release of active agents.

Latest Patents

Krill holds a patent for "Pharmaceutical formulations and systems for improved absorption and multistage release of active agents." This invention pertains to pharmaceutical formulations that deliver active agents in a unique manner. A first fraction of an active agent is suspended in a vehicle, while a second fraction is solubilized in the same vehicle. The suspended fraction constitutes about 5 wt. % to about 80 wt. % of the active agent, and the solubilized fraction represents about 20 wt. % to about 95 wt. %. This innovative formulation allows for rapid onset of action from the solubilized drug, while the suspended drug can be designed for delayed or sustained release.

Career Highlights

Krill is associated with Lipocine Inc., a company that focuses on developing innovative pharmaceutical products. His work has contributed to advancements in drug delivery systems, enhancing the effectiveness of medications.

Collaborations

He has collaborated with notable professionals in the field, including Feng-Jing Chen and Srinivasan Venkateshwaran. These collaborations have further enriched his research and development efforts.

Conclusion

Steven L. Krill's innovative work in pharmaceutical formulations exemplifies the potential for advancements in drug delivery systems. His contributions are paving the way for more effective treatments in the pharmaceutical industry.